Your browser doesn't support javascript.
loading
Performance of registration regulation policies on biosimilars in Japan and its enlightenment / 中国卫生政策研究
Chinese Journal of Health Policy ; (12): 50-55, 2016.
Article Dans Chinois | WPRIM | ID: wpr-508352
ABSTRACT

Objective:

This paper intends to provide reference for consummation of biosimilar registration poli-cies in China.

Methods:

This paper evaluates the performance of Japanese registration regulation policies on biosimi-lars by analyzing the procedure and reviewing the features of biosimilars. Results and

Conclusions:

According to the findings of the present investigation, the availability and affordability of biosimilars have been improved, and the bio-medicine industry has achieved great development. On the other hand, it's recommended that the guideline for the de-velopment and evaluation of biosimilars should be amended on the principle of appropriate simplification, which means to simplify the research and development procedure and exempt partial application dossier. Besides, the regis-tration procedures should be adopted continuously to ensure the stability of biosimilars' R&D and registration.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Health Policy Année: 2016 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Journal of Health Policy Année: 2016 Type: Article